NorthWest Biotherapeutics Inc (NWBO)

[TZOR]

Your argument is rendered feeble by two reasons, first Smith's last article where he mentioned Financial Position is Weak; there is a Need for Much More Cash

and

There is a great deal of uncertainty on the potential for success in this trial. If at the end of 2016, you assign a probability of success of 20%

You see balanced

AF try it some time, Try to get AF to say something like

If the data is as it portrays then the possibility of successfully meeting the endpoints is X%

He will not entertain the possibility of a successful trial, despite the fact that it could finish successfully surpassing its endpoints.

Feeble arguments cannot stand on their own, pal. Yours is a feeble argument.